Postes actifs de Olivier Lemaire
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ziphius Vaccines NV
 Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Directeur/Membre du Conseil | - | - |
| Compliance Officer | 01/07/2021 | - | |
| Conseiller Juridique Général | 01/07/2021 | - |
Historique de carrière de Olivier Lemaire
Statistiques
Internationale
| Belgique | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Compliance Officer | 1 |
| General Counsel | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Health Technology |
- Bourse
- Insiders
- Olivier Lemaire
- Expérience
